CAS 2071683-99-1

Fórmula: C20H30ClN3O3

InChI: InChI=1S/C20H29N3O3.ClH/c1-5-26-20(25)17(22-19(24)16(21)10-13(2)3)11-14-12-23(4)18-9-7-6-8-15(14)18;/h6-9,12-13,16-17H,5,10-11,21H2,1-4H3,(H,22,24);1H/t16-,17+;/m0./s1

Chave InChI: PXFDVONNVFXYEP-MCJVGQIASA-N

SMILES: CCOC(=O)[C@@H](CC1=CN(C2=CC=CC=C21)C)NC(=O)[C@H](CC(C)C)N.Cl

NLG802

CAS: 2071683-99-1

NLG802 is a prodrug of indoximod, an orally active indoleamine 2,3-dioxygenase (IDO) inhibitor.

Fórmula: C₂₀H₃₀ClN₃O₃

Pureza: 99.61%

Cor e Forma: Solid

Peso molecular: 395.924

Ref: TM-T39476

NLG802

CAS: 2071683-99-1

Fórmula: C₂₀H₃₀ClN₃O₃

Peso molecular: 395.9235

Ref: IN-DA023JTT

NLG802

CAS: 2071683-99-1

NLG802 is a small molecule that binds to the Ido1 receptor, which is an enzyme involved in the metabolism of asialoglycoprotein. This compound has demonstrated efficacy in animal models for autoimmune diseases and cancer. It can be used for the treatment of tumor cells expressing β-catenin with high sensitivity, such as glioma cells. NLG802 has been shown to have low toxicity in humans, and its pharmacokinetic properties are well understood. The molecule is rapidly eliminated from the body and has a short half-life.

Fórmula: C₂₀H₂₉N₃O₃·HCl

Pureza: Min. 95%

Ref: 3D-BN178095